Dry eye moves beyond palliative therapy.
Keratoconjunctivitis sicca, or dry eye syndrome, is a complex condition characterized by inflammation of the ocular surface and tear-producing glands. Emerging awareness of the etiology of dry eye has led to the development of highly effective therapy. When dry eye is controlled, there is significant potential for cost savings.
Sheppard
John D
JD
Eastern Virginia Medical School, USA.
D000367:Age Factors; D000368:Aged; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage; D016572:Cyclosporine / Q000008:administration & dosage; D005260:Female; D005569:Formularies as Topic; D017048:Health Care Costs; D006801:Humans; D007638:Keratoconjunctivitis Sicca / Q000150:complications / Q000188:drug therapy* / Q000191:economics; D008329:Managed Care Programs / Q000191:economics; D008875:Middle Aged; D010166:Palliative Care; D017060:Patient Satisfaction; D011788:Quality of Life
D000893:Anti-Inflammatory Agents; D016572:Cyclosporine